HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
about
Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal CancerHuman papillomavirus (HPV) infection: a Mozambique overview.Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkersBiologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.Programmable protein arrays for immunoprofiling HPV-associated cancers.Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.Serum Immune Profiling for Early Detection of Cervical Disease.Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low-risk, nontraditional patients.Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.
P2860
Q36737621-BFE85234-0054-430D-923C-96AEC01EE869Q37007475-BC794338-1ED4-4B1F-9EB4-8955834BE7F1Q37061534-AADA483B-749F-4304-BCA6-22BC0E8B09FFQ37170267-2ACEBA61-E977-44B9-A11B-63756CD8899CQ38377158-99FBF79B-82C9-4738-B816-93D482E2CA95Q39842946-CAA1898A-FF4C-4EFC-9439-9645A51C7442Q40045515-3379812B-BE41-4CA9-A1D3-25AC2A6E26B9Q40269751-A3CF571E-F96F-4896-B24B-74EA0AAE2FEBQ40289265-0CACA8D7-C87F-461D-BBA5-2047BA504A1AQ46015106-F4A00E00-1A9A-4197-BA54-F3F5C4DF0C33Q47094618-BD5A88A2-662D-4DED-9DF7-24D698CB0F20Q47677262-7FEF7A86-59DB-49E3-9845-DF8CC2EF8249Q50087551-F735ACFC-B280-4A2A-B4B6-3159DD03B8BDQ50743511-0A17752E-570D-46E7-B040-05808E36ECB1Q50799948-49F91D1B-80C9-46A2-ADA1-72F86A616BF8
P2860
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@ast
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@en
type
label
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@ast
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@en
prefLabel
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@ast
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@en
P2093
P2860
P1433
P1476
HPV16 antibodies as risk facto ...... tumor HPV and smoking status.
@en
P2093
Diego Chowell
Erich M Sturgis
Julia N Cheng
Karen S Anderson
Marshall Posner
Neil D Gross
Qingyi Wei
Rizwan Alam
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2015.04.011
P407
P577
2015-05-06T00:00:00Z